发明名称 |
COMBINED DRUG FOR TREATING DIABETES |
摘要 |
The present invention provides a pharmaceutical composition (preferably a drug for therapeutic and/or prophylactic treatment of diabetes) comprising a GLP-1 receptor agonist and the insulin resistance improving agent 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, or a pharmacologically acceptable salt thereof, in combination.
|
申请公布号 |
US2009227493(A1) |
申请公布日期 |
2009.09.10 |
申请号 |
US20060915734 |
申请日期 |
2006.05.26 |
申请人 |
DAIICHI SANKYO COMPANY, LIMITED |
发明人 |
NAKASHIMA RYUTARO;OGAWA JUNKO;OKUNO AKIRA |
分类号 |
A61K38/22;A61K31/427 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|